We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.11B
AUM Growth
+$673M
Cap. Flow
-$283M
Cap. Flow %
-6.89%
Top 10 Hldgs %
37.55%
Holding
125
New
30
Increased
16
Reduced
24
Closed
24

Top Buys

Rank Stock Value
1
AFIB
Acutus Medical Inc
AFIB
+$132M
2
CALC icon
CalciMedica
CALC
+$78.7M
3
NKTX icon
Nkarta
NKTX
+$71.3M
4
CNC icon
Centene
CNC
+$58.5M
5
OSH
Oak Street Health, Inc.
OSH
+$42.6M

Top Sells

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$123M
2
HOLX
Hologic
HOLX
+$62.2M
3
MCK icon
McKesson
MCK
+$42.7M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$31.2M
5
PCRX icon
Pacira BioSciences
PCRX
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 62.18%
2 Financials 1.23%
3 Industrials 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1
Viatris
VTRS
$20.1B
$197M 4.79%
13,274,000
+1,122,638
+9% +$17.9M
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$196M 4.77%
2,304,900
-256,100
-10% -$13M
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$142M 3.47%
1,832,767
-118,444
-6% -$8.15M
AFIB
4
DELISTED
Acutus Medical Inc
AFIB
$129M 3.15%
+4,341,799
New +$132M
DFPHU
5
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
$114M 2.78%
10,460,000
– –
CNC icon
6
Centene
CNC
$32.8B
$107M 2.6%
1,828,000
+942,000
+106% +$58.5M
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$96M 2.34%
704,000
– –
LRMR icon
8
Larimar Therapeutics
LRMR
$384M
$78M 1.9%
5,144,539
– –
NKTX icon
9
Nkarta
NKTX
$186M
$72.7M 1.77%
+2,418,772
New +$71.3M
PCRX icon
10
Pacira BioSciences
PCRX
$1.01B
$72M 1.75%
1,197,825
-465,175
-28% -$27M
CALC icon
11
CalciMedica
CALC
$11.6M
$67.1M 1.63%
+377,265
New +$78.7M
MIRM icon
12
Mirum Pharmaceuticals
MIRM
$7.25B
$66.5M 1.62%
3,448,912
– –
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
$66.3M 1.61%
579,248
+393,248
+211% +$42.4M
RVMD icon
14
Revolution Medicines
RVMD
$39.6B
$62.5M 1.52%
1,796,383
– –
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
$58.8M 1.43%
1,234,262
– –
OSH
16
DELISTED
Oak Street Health, Inc.
OSH
$50.8M 1.24%
+951,063
New +$42.6M
ANNX icon
17
Annexon
ANNX
$950M
$48.9M 1.19%
+1,617,826
New +$38M
XLRN
18
DELISTED
Acceleron Pharma
XLRN
$47.4M 1.16%
421,619
– –
BKD icon
19
Brookdale Senior Living
BKD
$3.58B
$45M 1.1%
17,720,000
+3,809,101
+27% +$10.5M
RETA
20
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$43.6M 1.06%
448,000
+186,235
+71% +$23.3M
RYTM icon
21
Rhythm Pharmaceuticals
RYTM
$7.31B
$41.1M 1%
1,897,047
-572,966
-23% -$13.1M
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
$39.6M 0.96%
776,000
-632,603
-45% -$26.4M
BPMC
23
DELISTED
Blueprint Medicines
BPMC
$37.6M 0.92%
405,386
– –
AHCO icon
24
AdaptHealth
AHCO
$1.49B
$37.3M 0.91%
1,710,674
+321,333
+23% +$6.75M
ACH
25
Accendra Health
ACH
$266M
$37.1M 0.9%
1,477,000
– –
1
2 3 4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q3 2020 Portfolio in Review

As of Q3 2020, Deerfield Management held 125 positions worth $4.11B, up 20% from $3.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Deerfield Management withdrew a net $283M in Q3 2020, closing 24 positions and reducing 24 holdings. Its most notable exit was Schrodinger, an estimated $123M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 66% a quarter earlier, followed by Financials and Industrials.

Against the trend, Deerfield Management opened a new position in Acutus Medical Inc worth $129M.

  • Deerfield Management's largest Q3 2020 buy was Acutus Medical Inc: 4,341,799 shares worth $129M.
  • Deerfield Management added most to Centene in Q3 2020, an estimated $58.5M increase.
  • Deerfield Management's biggest Q3 2020 reduction was Hologic, cutting an estimated $62.2M.
  • Deerfield Management fully exited Schrodinger in Q3 2020, selling an estimated $123M.
  • Deerfield Management's ten largest holdings make up 38% of its $4.11B portfolio in Q3 2020.
  • Deerfield Management opened 30 new positions and closed 24 in Q3 2020.
  • Deerfield Management's portfolio value rose 20% quarter-over-quarter to $4.11B.

Based on Deerfield Management's 13F filing for Q3 2020, filed 16 Nov 2020.